Paper Details

  1. Home
  2. Paper Details

Bupropion and cognitive-behavioral therapy for smoking cessation in women.

Author: DelauneKatherine A, MoellerGerard F, MooneyMarc E, SchmitzJoy M, StottsAngela L

Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Bupropion combined with cognitive-behavioral therapy (CBT) was more effective in promoting smoking cessation in women than bupropion with supportive therapy. However, the combination of bupropion and CBT was not clearly superior to placebo. Compliance with medication was an important factor influencing treatment success.
Paper Details　
Original Abstract of the Article :
Gender data for bupropion suggest that it may be a particularly effective smoking cessation medication for women. It is not known whether the efficacy of this pharmacotherapy differs as a function of the psychotherapy with which it is administered. This study used a two level factorial design to exa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14622200701365335

データ提供：米国国立医学図書館（NLM）

Bupropion and Cognitive-Behavioral Therapy: A Winning Combination for Smoking Cessation in Women?

This study investigated the efficacy of bupropion, a smoking cessation medication, in combination with different types of psychotherapy for women. The researchers used a two-level factorial design to examine the independent and interactive effects of bupropion (300 mg/day vs. placebo) and psychotherapy (cognitive-behavioral therapy [CBT] vs. supportive therapy [ST]). They found that while the combination of bupropion and CBT showed higher abstinence rates at the end of treatment and during follow-up compared to bupropion with ST or placebo, it did not consistently outperform placebo alone. The study also revealed that medication compliance played a significant role in the effectiveness of bupropion, with higher compliance levels predicting better abstinence outcomes.

Medication Compliance: A Crucial Factor in Smoking Cessation

This research highlights the crucial role of medication compliance in smoking cessation. The study found that higher rates of medication compliance were associated with increased abstinence rates, suggesting the importance of patient adherence to treatment protocols. This finding emphasizes the need for strategies to improve medication compliance and enhance the success rate of smoking cessation interventions.

The Journey to Quitting: A Balancing Act of Mind and Medication

This study provides a glimpse into the complex world of smoking cessation, showcasing the intricate interplay of medication, therapy, and individual factors. The findings suggest that while bupropion can be a helpful tool, it's not a magic bullet. Just like a camel navigating a desert, quitting smoking requires a multifaceted approach, combining willpower, support, and potentially medication. This research encourages a holistic approach to smoking cessation, acknowledging the importance of both psychological and pharmacological interventions, along with the crucial role of medication compliance.

Dr.Camel's Conclusion

This study is like a desert oasis, providing a cool respite from the heat of nicotine addiction. It reminds us that quitting smoking is a journey, not a destination, and that the path requires a combination of mental fortitude, external support, and potentially medication. It's essential to keep a steady pace and stay committed to achieving that elusive goal, just as a camel perseveres on a long and arduous trek through the desert.

Date :
  1. Date Completed 2007-09-13
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17558827

DOI: Digital Object Identifier

10.1080/14622200701365335

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.